Form D — Dualitas Therapeutics, Inc.

0001231919-25-000517 · filed Nov 18, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $66,599,990
Reported amount sold: $32,599,997
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Dualitas Therapeutics, Inc.
CIK: 2091994
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2023
Address: 681 GATEWAY BOULEVARD, SUITE 411
SOUTH SAN FRANCISCO, CA 94080
Phone: (917) 640-1086

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Richard Murray · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Forbes Huang · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Nikola Trbovic · Director

South San Francisco, CA Find on LinkedIn ↗
Neil Weir · Director

South San Francisco, CA Find on LinkedIn ↗
Alicia Levey · Director

South San Francisco, CA Find on LinkedIn ↗
Thomas Hudson · Director

South San Francisco, CA Find on LinkedIn ↗
Mark McDade · Director

South San Francisco, CA Find on LinkedIn ↗
Greg Lazar · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Michael Ross · Director

South San Francisco, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗